Immediate Impact
51 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
2025 Standout
Works of Xianfu Sun being referenced
Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial
2023
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Xianfu Sun | 208 | 251 | 266 | 41 | 543 | |
| Kristen E. Muller | 256 | 148 | 185 | 41 | 555 | |
| Tao Fu | 133 | 207 | 274 | 39 | 583 | |
| Yong Dong | 170 | 217 | 225 | 22 | 585 | |
| Kateřina Bouchalová | 225 | 125 | 188 | 34 | 470 | |
| Yunxiang Zhang | 188 | 114 | 188 | 42 | 519 | |
| Qingyang Gu | 228 | 148 | 341 | 26 | 636 | |
| Xiuli Xiao | 167 | 240 | 351 | 29 | 649 | |
| Ping Wen | 190 | 205 | 288 | 33 | 579 | |
| Shude Cui | 279 | 268 | 231 | 42 | 590 | |
| Masahiro Ohara | 296 | 204 | 191 | 44 | 636 |
All Works
Login with ORCID to disown or claim papers
Loading papers...